Cover Image

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features

(1) Background: Colistin-only susceptible (COS) <i>Acinetobacter baumannii</i> (AB) ventilator-associated pneumonia (VAP) represents a clinical challenge in the Intensive Care Unit (ICU) due to the negligible lung diffusion of this molecule and the low-grade evidence on efficacy of its n...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gennaro De Pascale (Author), Gabriele Pintaudi (Author), Lucia Lisi (Author), Flavio De Maio (Author), Salvatore Lucio Cutuli (Author), Eloisa Sofia Tanzarella (Author), Simone Carelli (Author), Gianmarco Lombardi (Author), Melania Cesarano (Author), Veronica Gennenzi (Author), Gabriella Maria Pia Ciotti (Author), Domenico Luca Grieco (Author), Brunella Posteraro (Author), Maurizio Sanguinetti (Author), Pierluigi Navarra (Author), Massimo Antonelli (Author)
Format:	Book
Published:	MDPI AG, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections
by: Anna Kyriakoudi, et al.
Published: (2022)

Intrapulmonary and Systemic Pharmacokinetics of Colistin Following Nebulization of Low-Dose Colistimethate Sodium in Patients with Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Dong-Hwan Lee, et al.
Published: (2024)

Efficacy of adjuvant colistimethate sodium nebulization in ventilator associated pneumonia in pediatric intensive care unit - A randomized controlled study
by: Anil Sachdev, et al.
Published: (2019)

Antimicrobial De-Escalation in Critically Ill Patients
by: Eloisa Sofia Tanzarella, et al.
Published: (2024)

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>) and <i>Pseudomonas aeruginosa</i> to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
by: Venere Cortazzo, et al.
Published: (2022)

The Incidence of VAP after VAP Bundle Intervention Among Patients with Mechanical Ventilation
by: Diah Susmiarti, et al.
Published: (2015)

Curcumin-Functionalized Graphene Oxide Strongly Prevents <i>Candida parapsilosis</i> Adhesion and Biofilm Formation
by: Margherita Cacaci, et al.
Published: (2023)

Usage of colistimethate sodium, is it rational or rampant? - A tertiary care oncology centre self audit
Published: (2017)

Usage of colistimethate sodium, is it rational or rampant? - A tertiary care oncology centre self audit
by: Jaikumar Ramamoorthy, et al.
Published: (2017)

Hand hygiene and facemask use to prevent droplet-transmitted viral diseases during air travel: a systematic literature review
by: Giulia De Angelis, et al.
Published: (2021)

Clinical Features and Outcomes of VAP Due to Multidrug-Resistant <i>Klebsiella</i> spp.: A Retrospective Study Comparing Monobacterial and Polybacterial Episodes
by: Dalia Adukauskiene, et al.
Published: (2023)

<i>Mycobacterium tuberculosis</i> Rv0229c Shows Ribonuclease Activity and Reveals Its Corresponding Role as Toxin VapC51
by: Sung-Min Kang
Published: (2023)

Utilizing liposomal encapsulation approach to address nephrotoxic challenges of colistimethate sodium through a preclinical study
by: Raktham Mektrirat, et al.
Published: (2023)

The incidence of ventilator-associated pneumonia (VAP) in a tertiary-care center: Comparison between pre- and post-VAP prevention bundle
by: Sara Osman, et al.
Published: (2020)

Knowledge of Guideline VAP Bundle Improves Nurse Compliance Levels in Preventing Associated Pneumonia (VAP) Ventilation in the Intensive Care Unit
by: Siti Saodah
Published: (2019)

Description of Clinical Characteristics of VAP Patients in MIMIC Database
by: Qingqing Liu, et al.
Published: (2019)

APACHE II as an indicator of ventilator-associated pneumonia (VAP).
by: Kelser de Souza Kock, et al.
Published: (2015)

Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures
by: Giulia Menchinelli, et al.
Published: (2024)

Co-Administration of High-Dose Nebulized Colistin for <i>Acinetobacter baumannii</i> Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes
by: Ioannis Andrianopoulos, et al.
Published: (2024)

The Role of Mannose-Binding Lectin in Severe Sepsis and Septic Shock
by: Gennaro De Pascale, et al.
Published: (2013)

Commentary: Description of Clinical Characteristics of VAP Patients in MIMIC Database
by: Yun Li, et al.
Published: (2021)

The application of antimicrobials in VAP patients requiring ECMO supportive treatment
by: Dongna Zou, et al.
Published: (2022)

Periodontitis leads to VAP in ICU patients: A dental note
by: Rajiv Saini, et al.
Published: (2010)

<i>Fear Appeal</i> e <i>Message Framing</i> Strategie persuasive in interazione per la promozione della salute
by: Gianmarco Romani
Published: (2013)

Nebulizers: Debunking Myths
by: L. S. Namazova-Baranova
Published: (2017)

Ventilator-Associated Pneumonia (VAP) in a Patient with Guillain-Barre Syndrome
by: Anti Dharmayanti, et al.
Published: (2017)

Increasing Detection of Legionnaires' Disease in a Large Italian Hospital in the Period 2016-2023
by: Marilena La Sorda, et al.
Published: (2024)

Comparative study of magnesium sulphate nebulization and lignocaine nebulization in prevention of postoperative sore throat (POST)
by: Gopal Sharma, et al.
Published: (2023)

Nebulizations: are they a safe practice?
by: Cipatli Ayuzo-del Valle, et al.
Published: (2022)

Theory of Planned Behavior Development Model to Compliance Behavior in Vap Prevention at ICU
by: Kusnanto Kusnanto, et al.
Published: (2020)

High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia in Critically Ill Patients: A Retrospective Cohort Study
by: Wasan Katip, et al.
Published: (2024)

Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"
by: Khalil Chaïbi, et al.
Published: (2022)

Comparison of efficacies of full and abbreviated cascade impactors in aerosol characterization of nebulized salbutamol sulfate produced by a jet nebulizer
by: Nattika Nimmano, et al.
Published: (2021)

The Effects of Self- Efficacy and Anxiety Levels of Mothers With Children Receiving Nebulized Inhalation Treatment on the Application of Nebulized Inhalation Practices
by: Duygu Arıkan, et al.
Published: (2022)

Direct Testing for KPC-Mediated Carbapenem Resistance from Blood Samples Using a T2 Magnetic Resonance Based Assay
by: Giulia De Angelis, et al.
Published: (2021)

Comparison of clinical outcomes following delivery of budesonide by both vibrating mesh nebulizer and jet nebulizer in premature infants with bronchopulmonary dysplasia
by: Jian-Fu Zhou, et al.
Published: (2023)

New Form of Hypertonic Solution for Nebulization Therapy
by: Olga I. Simonova, et al.
Published: (2016)

Effects of Nebulized Adrenaline on Cardiac Rhythm in Children
by: Halise Akça, et al.
Published: (2019)

Efficacy of nebulized magnesium sulfate in moderate bronchiolitis
by: N Guruprasad, et al.
Published: (2022)

Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects
by: Greta Adorni, et al.
Published: (2019)